Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter Trial With an Enriched Study Design to Assess the Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Pain Due to Chronic Low Back Pain Who Require Around-the-clock Opioid Therapy
NCT01358526 is registered in ClinicalTrials.gov with Purdue Pharma LP as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled, Multicenter Trial With an Enriched Study Design to Assess the Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Pain Due to Chronic Low Back Pain Who Require Around-the-clock Opioid Therapy
- Lead sponsor
- Purdue Pharma LP
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- November 30, 2012
- Enrollment
- 1,095 (actual)
- Sites
- 151
Conditions
As the registry lists them; a condition with its own page is linked.